Supplemental material
Hematology
Volume 28, 2023 - Issue 1
Research Article
MPL gene mutation is a possible risk factor for thrombosis in patients with essential thrombocythemia in Japan
, 
, , , , , , , & show all
Yoshinori Hashimotob Department of Hematology, Tottori Prefectural Central Hospital, Tottori City, Japan;c Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japanhttps://orcid.org/0000-0002-3374-9814View further author information
https://orcid.org/0000-0002-3374-9814View further author information, Soji Morishitac Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;d Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japanhttps://orcid.org/0000-0003-1081-0130View further author information
https://orcid.org/0000-0003-1081-0130View further author information, Tadaaki Inanoa Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japanhttps://orcid.org/0000-0002-9618-6588View further author information
https://orcid.org/0000-0002-9618-6588View further author information, Tomonori Ochiaia Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;c Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;d Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japanhttps://orcid.org/0000-0001-6156-4211View further author information
https://orcid.org/0000-0001-6156-4211View further author information, , Yoko Edahiroa Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;c Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;d Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japanhttps://orcid.org/0000-0002-8386-1871View further author information
https://orcid.org/0000-0002-8386-1871View further author information, Marito Arakic Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;d Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japanhttps://orcid.org/0000-0002-3502-5000View further author information
https://orcid.org/0000-0002-3502-5000View further author information, & Norio Komatsua Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;c Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;d Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan;e PharmaEssentia Japan KK, Tokyo, JapanCorrespondence[email protected]
https://orcid.org/0000-0003-1880-9126View further author information
https://orcid.org/0000-0003-1880-9126View further author information show all